171 related articles for article (PubMed ID: 16989181)
21. Treatment of hepatitis B virus infection in patients coinfected with HIV.
Benhamou Y; Bonyhay L
Gastroenterol Clin North Am; 2004 Sep; 33(3):617-27, x. PubMed ID: 15324947
[TBL] [Abstract][Full Text] [Related]
22. Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B.
Singal AK; Salameh H; Kuo YF; Fontana RJ
Aliment Pharmacol Ther; 2013 Jul; 38(2):98-106. PubMed ID: 23713520
[TBL] [Abstract][Full Text] [Related]
23. [The clinical study of adding on adefovir dipivoxil to treat for lamivudine resistant patients with chronic hepatitis B].
DING JG; SUN QF; FU RQ; WU YH; HONG L
Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):387-8. PubMed ID: 19497209
[No Abstract] [Full Text] [Related]
24. [Treatment of chronic hepatitis B].
Asselah T; Castelnau C; Marcellin P
Presse Med; 2006 Feb; 35(2 Pt 2):327-34. PubMed ID: 16493337
[TBL] [Abstract][Full Text] [Related]
25. [The first nucleotide analog permitted. New hepatitis B therapy helps the problem patients, too].
MMW Fortschr Med; 2003 Jun; 145(24):52. PubMed ID: 12866303
[No Abstract] [Full Text] [Related]
26. Pharmacotherapy of hepatitis B infection: a brief review.
Quan DJ
Nephrol Nurs J; 2008; 35(5):507-10, 534. PubMed ID: 18856082
[TBL] [Abstract][Full Text] [Related]
27. [New developments in therapy of chronic hepatitis B. When are nucleoside analogs indicated?].
Petry W; Erhardt A; Heintges T; Häussinger D
Z Gastroenterol; 2000 Jan; 38(1):77-87. PubMed ID: 10689749
[TBL] [Abstract][Full Text] [Related]
28. Meta-analysis: oral anti-viral agents in adults with decompensated hepatitis B virus cirrhosis.
Singal AK; Fontana RJ
Aliment Pharmacol Ther; 2012 Mar; 35(6):674-89. PubMed ID: 22257108
[TBL] [Abstract][Full Text] [Related]
29. Chronic hepatitis B: a wider range of therapeutic options.
Prescrire Int; 2007 Aug; 16(90):157-62. PubMed ID: 17724844
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic options for chronic hepatitis B: considerations and controversies.
Jacobson IM
Am J Gastroenterol; 2006; 101 Suppl 1():S13-8. PubMed ID: 16448447
[TBL] [Abstract][Full Text] [Related]
31. Optimal duration of therapy in HBV-related cirrhosis.
Lim CY; Kowdley KV
J Antimicrob Chemother; 2007 Jul; 60(1):2-6. PubMed ID: 17483546
[TBL] [Abstract][Full Text] [Related]
32. Antiviral options for the treatment of chronic hepatitis B.
Osborn MK; Lok AS
J Antimicrob Chemother; 2006 Jun; 57(6):1030-4. PubMed ID: 16595637
[TBL] [Abstract][Full Text] [Related]
33. Treatment of HBeAg-negative chronic hepatitis B.
Hadziyannis SJ; Papatheodoridis GV; Vassilopoulos D
Semin Liver Dis; 2003 Feb; 23(1):81-8. PubMed ID: 12616453
[TBL] [Abstract][Full Text] [Related]
34. [Current treatment of hepatitis B].
Suárez García E; Romero Gómez M; Grande Santamaría L
Gastroenterol Hepatol; 2001 Feb; 24 Suppl 1():35-50. PubMed ID: 11279893
[No Abstract] [Full Text] [Related]
35. Randomized trial of lamivudine, adefovir, and the combination in HBeAg-positive chronic hepatitis B.
He Z; Wang J; Liu K; Huang H; Du Y; Lin Z; Cai M; Feng X
Clin Res Hepatol Gastroenterol; 2012 Dec; 36(6):592-7. PubMed ID: 23069315
[TBL] [Abstract][Full Text] [Related]
36. [A study on the treatment of chronic hepatitis B with YMDD mutation].
Qiu YW; Jiang XH; Huang LH; Hu TH; Ding H; Jiang YM; Dai YX; Zhou M
Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):171-4. PubMed ID: 19335977
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of adefovir dipivoxil 20 mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10 mg daily.
Hézode C; Chevaliez S; Bouvier-Alias M; Roudot-Thoraval F; Brillet R; Zafrani ES; Dhumeaux D; Pawlotsky JM
J Hepatol; 2007 May; 46(5):791-6. PubMed ID: 17321635
[TBL] [Abstract][Full Text] [Related]
38. Advances in therapy for chronic hepatitis B.
Marcellin P
Semin Liver Dis; 2002; 22 Suppl 1():33-6. PubMed ID: 12447727
[TBL] [Abstract][Full Text] [Related]
39. Chronic hepatitis B with advanced fibrosis or cirrhosis: impact of antiviral therapy.
Arora G; Keeffe EB
Rev Gastroenterol Disord; 2007; 7(2):63-73. PubMed ID: 17597674
[TBL] [Abstract][Full Text] [Related]
40. [A clinical study of adefovir dipivoxil treatment for chronic hepatitis patients with cirrhosis in their decompensation period].
Yang Q; Gong ZJ; Hu DF
Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):515-9. PubMed ID: 19912686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]